Arax Advisory Partners’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.41K	Buy	+454	New	+$2.41K	﹤0.01%	2497
2024 Q4	–	Sell	-51	Closed	-$1.4K	–	2626
2024 Q3	$1.4K	Hold	51	–	–	﹤0.01%	2157
2024 Q2	$1.25K	Buy	+51	New	+$1.25K	﹤0.01%	2107